Drug Distribution Stocks Scatter Chart

11 companies Industry in Healthcare P/E vs Revenue Growth (1y) (TTM)
Universe
Plot any two of 343 metrics The preset pairs are free. Subscribers can put any metric on either axis.
Highlight

P/E vs Revenue Growth (1y) (TTM)

Company Outlier, pinned to the edge Highlighted Trend

Each dot is one of the 11 Drug Distribution stocks, sized by market cap. The median Revenue Growth (1y) (TTM) is 8.2% and the median P/E 22.79. Pinned to the edge: 1 outliers on X and 0 on Y.

Rank correlation 0.15 Trend R² 0.00 X middle half 5.6% to 11.3% Y middle half 16.79 to 35.90
4High Revenue Growth (1y) (TTM), high P/E
2Low Revenue Growth (1y) (TTM), high P/E
3Low Revenue Growth (1y) (TTM), low P/E
2High Revenue Growth (1y) (TTM), low P/E

Quadrants split at the medians. Hover a dot for its true values; click to open the company. Outliers are more than 3× the interquartile range beyond the quartiles.

Companies

11 plotted
# Industry
1 MCKMckesson 8.2% 27.29 $127.33B Drug Distribution
2 CORCencora 5.0% 22.64 $68.51B Drug Distribution
3 CAHCardinal Health 10.0% 35.87 $64.97B Drug Distribution
4 BTSGBrightSpring Health Services 26.0% 35.93 $14.16B Home Health and Senior Care
5 HSICHenry Schein 6.2% 22.79 $9.53B Drug Distribution
6 AMRXAmneal Pharmaceuticals 8.9% 53.85 $7.45B Generic Drugs
7 GRDNGuardian Pharmacy Services 4.9% 41.91 $3.13B Drug Distribution
8 AVAHAveanna Healthcare Holdings 16.8% 8.18 $2.51B Home Health and Senior Care
9 SBCSBC Medical Group Holdings 6.7% 14.53 $755.93M Healthcare Services
10 KMDAKamada 12.6% 19.04 $466.68M Biotechnology
11 OSRHOSR Health -50.4%OUT 0.71 $3.51M Biotechnology

Frequently Asked Questions

Which Drug Distribution stocks look cheap relative to their growth?

Among Drug Distribution stocks, the largest companies growing revenue faster than the median (8.2%) while trading below the median P/E (22.79) are Aveanna Healthcare Holdings (AVAH) and Kamada (KMDA). A low multiple next to fast growth can be an opportunity or a sign the market doubts the growth will last.

Which Drug Distribution stocks are expensive for their growth?

The largest companies with a P/E above the median and revenue growth below it are Henry Schein (HSIC) and Guardian Pharmacy Services (GRDN).

What is the median P/E of Drug Distribution stocks?

The median P/E across the 11 Drug Distribution stocks plotted is 22.79, with the middle half between 16.79 and 35.90.

What is the median Revenue Growth (1y) (TTM) of Drug Distribution stocks?

The median is 8.2%, with the middle half between 5.6% and 11.3%.

Is there a relationship between Revenue Growth (1y) (TTM) and P/E for Drug Distribution stocks?

The rank correlation (Spearman) is 0.15, a weak positive relationship: companies with a higher Revenue Growth (1y) (TTM) tend to have a higher P/E.

How does this chart handle outliers?

A company whose value lies more than three interquartile ranges beyond the first or third quartile is treated as an outlier. By default it stays on the chart, pinned to the edge as an open marker, and its true value is shown in the tooltip and the table. In this view 1 companies are outliers on Revenue Growth (1y) (TTM) and 0 on P/E. You can switch to percentile clamping, exclude outliers, or plot raw values on a log scale.

Metrics from Business Quant's screener: trailing-twelve-month figures from SEC filings and multiples on the latest close. A company appears once even when it lists more than one share class. A company with a secondary business line in this industry is included unless you choose primary industry only. Nothing on this page is investment advice.